Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_1
3
75%
Ph phase_4
1
25%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (75.0%)
Phase 41 (25.0%)

Trials by Status

unknown250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

Recovery and Analgesia After Surgery for Gynecological Cancer

NCT02026687
unknownphase_1

Efficacy of Intrathecal Versus Intravenous Dexmedetomidine for Prevention of Post Spinal Anesthesia Shivering

NCT02965586
unknownphase_1

Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment

NCT02034669
completedphase_1

Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury

NCT01186679

Clinical Trials (4)

Showing 4 of 4 trials
NCT02026687Phase 4

Recovery and Analgesia After Surgery for Gynecological Cancer

Completed
NCT02965586Phase 1

Efficacy of Intrathecal Versus Intravenous Dexmedetomidine for Prevention of Post Spinal Anesthesia Shivering

Unknown
NCT02034669Phase 1

Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment

Unknown
NCT01186679Phase 1

Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4